Atria Investments Inc Sells 12,129 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Atria Investments Inc lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 74,562 shares of the healthcare conglomerate’s stock after selling 12,129 shares during the quarter. Atria Investments Inc’s holdings in UnitedHealth Group were worth $37,718,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of UNH. M&T Bank Corp raised its position in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after buying an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after buying an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. grew its position in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after acquiring an additional 41,308 shares during the last quarter. Parsifal Capital Management LP purchased a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC lifted its stake in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $474.58 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market cap of $436.74 billion, a price-to-earnings ratio of 30.62, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm’s 50-day moving average is $515.18 and its 200 day moving average is $555.37.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.83 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.77%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.